Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
38 Cards in this Set
- Front
- Back
MS prevalance
|
Northern NE
Much more common in women |
|
Genetic predisp of MS
|
DR2 predominant.
|
|
Relapsing-remitting MS
|
Most common.
Attack, disability, return almost to baseline, repeat. |
|
Secondary progressive MS
|
Second most common
After disability, basically no return to a baseline. But it stays there for a while. So it gets worse much quicker the RRMS. |
|
Primary progressive MS
|
Later onset, male dominant.
Patient just gradually gets worse and worse. |
|
Progressive relapsing MS
|
After disability, It goes back to baseline but then gradually gets worse. Then there is a quick jump up in disability. Repeat.
|
|
Dx of MS - general
|
Easily missed, must be thinking about it.
Also it is kinda treatable, so early detection is critical. |
|
What is an MS attack?
|
This is what causes the disability.
Can be subjective (e.g. change in sensory) or objective (strange gait, vision change, etc.) 24 hour duration minimum Must be 30 day gap between attacks. |
|
Psuedoattack
|
not a true MS attack
It lasts less than 24 hours. |
|
Pathophys of MS
|
T cell activated and upregulated Alpha-4-beta-1. This recognizes VCAM on BBB and chemokines are secreted to allow metalloproteinases to break BBB and let T cell in.
The T cell is then reactivated in CNS (most likely by a B cell) and then NO eventually causes demyelination. |
|
Common clincial sx of MS
|
Fatigue (due to IL-6 - just like in CA)
Numbness Optic Neuritis Weakness (hemiparesis or transverse myelitis) Diplopia Poor coordination (gait ataxia, dysmetria) Short-term memory loss (executive functions) Depression and sexual dysfunction Bladder and bowel dysfunction Slurred speech IT IS ALSO A DISEASE OF GRAY MATTER!!! |
|
Time/space dissemination
|
Two neuro events must be separated by 30 days and two anatomic events must be confirmed (e.g. optic neuritis and leg parasthesia).
|
|
Dx criteria of MS
|
Often a dx of exclusion
Not due to another disease (lupud, thyroid, B12, Lyme, etc.) Time/space dissemination Positive MRI |
|
3 categories of MS dx
|
Clinically defined - all criteria met
Probable - All criteria met except only one objective change on exam despite two symptomatic episodes or one symptomatic episode and 2+ objective changes. At risk for MS - all criteria met except only 1 symptomative and 1 objective finding on exam. Or it is a clinically isolated syndrome (a 1 time neurological episode) |
|
MRI - T1
|
ASSESSMENT OF THE DEGEN PROCESS
Assess black holes and atrophies determined by brain paraenchymal fraction. This is ebcasue inflammation over time causes holes in the brain near the ventricles and they fuse together to reduce brain mass. |
|
MRI - T2
|
ASSESS INFLAMMATORY PROCESS
AKA FLAIR-assess disease burden. |
|
MRI - T1 plus gadolinium
|
Assess recent events disrupting BBB. To tell if it is active within past 2-4 weeks.
|
|
Upwards extensions on sagittal view of MRI (from corpus callosum)
|
Dawson's fingers
very characteristic of MS. |
|
Positive MRI for MS
|
3/4:
1 gadolinium enhancing CNS lesion or 9 T2 (or FLAIR) hyperintensities 1 or more cord/infratentorial lesion 1 or more juxtacortical lesion 3 or more paraventricular lesions. |
|
2 other lab studies to confirm MS
|
Positive CSF - oligoclonal IgG bands in CSF, and not in serum. (this is bc there are b cell germinal centers in brains of MS patients. Must also have low cellularity)
Positive VER - (visual evoked response) - Asymm. in time for optic nerve signal to get to back of brain - signals demyelination. Wave form will be delayed but well preserved. |
|
2 parts of MS
|
1st part - inflammatory
2nd part - degenerative |
|
What happens to axons in MS?
|
Transected (cut) - independent of areas of inflammation.
|
|
MS is an ____ disease
|
immunological!
(remember, ventricles will expand dramatically) |
|
Pro-inflammatory and neurotoxic factors
|
IL-17,2
Th1 cytokines TNF alpha NO ROS glutamate Abs and complement cell-mediated neurotoxicity. |
|
Anti-inflammatory and neuroprot. factors
|
Th2
TGF-beta IL-10 Neurotrophic factors (BDNF, NGF, NT-3, CNTF, GDNF) |
|
Tregs in MS
|
Dysfunctional. Missing foxp3.
|
|
BDNF levels in MS
|
increase during relapses and recovery to repair damaged tissue.
Dramatic increase near MS lesions. |
|
IFN-beta
|
All injections
Avonex (lose dose - once per week) Betaseron (every other day - "qod") or Rebif (3x per week) This is pro-inflammatory normally, but at high levels it turns itself off. Used in tx of relapsing MS. For RRMS |
|
Glatiramer acetate (Copaxone)
|
For RRMS or clinically isolated syndrome
It is random AAs that is the core of myelin basic protein. Shifts to a Th2 response and assists TRegs. |
|
Natalizumab (Tysabri)
|
RRMS
Antibody to alpha-4-beta-1 so T cells can't cross BBB. Also used for Crohn's disease. Can cause bad infections |
|
Mitoxantrone
|
For secondary progressive MS. A chemo agent.
|
|
IFN beta mech of action
|
Downreg matrix metalloproteinases (they break BBB) and make more soluble VCAM receptor (to outcompete the VCAM on BBB). Also downreg IL-12 (key to autoimmune diseases).
This decreases Gd enhancing activity (less BBB instability) and promotes neuroprotection |
|
Glatiramer acetat (Copraxone)e mech of action
|
Induces TH2 shift.
Neuroprotection |
|
Interferon SE
|
Flulike sx, leukopenia, high LFTs
|
|
glatiramer acetate (Copaxone) SE
|
Injection site rxn and chest pain.
|
|
Mitoxantrone SE
|
Want to use it sparingly bc it is a chemo agent. Cardio toxicity and leukopenia. and N/V
|
|
Natalizumab (Tysabri) SE
|
Opportunistic infections and survival of tumor cells.
|
|
MS - whole brain phenomena - other sx
|
weakness, spasticity, pain, depression, bladder
|